Erkang Fei

7.7k citations
46 papers · 1.3k indexed · h-index 22
Topics
Mitochondrial Function and Pathology (7 papers)Genetic Neurodegenerative Diseases (7 papers)Neuroscience and Neuropharmacology Research (6 papers)
Partner nations
ChinaJapanUnited States

In The Last Decade

Erkang Fei

46 papers receiving 1.3k citations

Peers

Erkang Fei
Comparison fields: 5 of 96
  • Molecular Biology 780
  • Cellular and Molecular Neuroscience 415
  • Neurology 309
  • Epidemiology 209
  • Cell Biology 202
Replace Wendou Yu with:
Wendou Yu United States
Michael Bidinosti Canada
Milena Pinto United States
Anh H. Pham United States
Kerry Purtell United States
Hanna Wootz Sweden
Mügen Terzioglu Finland
Andrii Domanskyi Finland
Xavier Xifró Spain
Srinivasa Subramaniam United States
Erkang Fei relative to Wendou Yu United States Wendou Yu's profile →
Citations per field
00.5×
Wendou Yu · 1×
Citations per year

Countries citing papers authored by Erkang Fei

Since Specialization
Citations

This map shows the geographic impact of Erkang Fei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erkang Fei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erkang Fei more than expected).

Fields of papers citing papers by Erkang Fei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erkang Fei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erkang Fei. The network helps show where Erkang Fei may publish in the future.

Co-authorship network of co-authors of Erkang Fei

This figure shows the co-authorship network connecting the top 25 collaborators of Erkang Fei. A scholar is included among the top collaborators of Erkang Fei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erkang Fei. Erkang Fei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 13
2 1
3 3
4 8
5 6
6 26
7 22
8 17
9 5
10 21
11 26
12 21
13 27
14 28
15 42
16 52
17 117
18 8
19 45
20 40

About Erkang Fei

Erkang Fei is a scholar working on Cellular and Molecular Neuroscience, Cell Biology and Aging, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (7 papers), Genetic Neurodegenerative Diseases (7 papers) and Neuroscience and Neuropharmacology Research (6 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (415 citations), Neurology (309 citations) and Biological Psychiatry (33 citations). Erkang Fei has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Guanghui Wang, Haigang Ren, Nali Jia, Tian Zhou, Hongfeng Wang, Zheng Ying, Mian Wu, Peng Jiang, Jun Fan and Bin Li. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026